close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

Head of Innovative Medicines Initiative at the European Commission to Deliver Keynote Address at ICR European Conference in November

BIRMINGHAM, England, July 4, 2007--The 3rd European Conference and Exhibition of the Institute of Clinical Research (ICR) will take place in Belgium from 8th to 9th November 2007. Attendees at the event will engage in debate on the key issues regarding EUROPE - the best place in the world to do clinical research?


At the conference, international clinical research professionals will hear presentations from leading European experts to stimulate discussion on a variety of topics including quality, diversity, funding and legislative matters.


Irene Norstedt, head of sector for the innovative medicines initiative at the European Commission will address the advantages of conducting clinical research in Europe.


The conference and exhibition is being held at the Le Plaza Hotel in Brussels from mid-day on Thursday 8th November until lunch-time on Friday 9th November 2007.


Dr John Hooper, the ICR's chief executive, commented: "Our expert speakers from the European Commission, European Medicines Agency, major pharmaceutical companies and other leading organisations should provoke some excellent debate."


Ms Norstedt has been working with various aspects of European Life Sciences research at the European Commission since 1996. She is currently responsible for SME/industrial aspects of health/biotechnology within the Health Research Directorate. She has a MSc in Chemical Engineering from the Royal Institute for Technology in Stockholm and a degree in Pharmaceutical sciences.


The event will also address issues affecting the operation of clinical research in Europe and the critical factors influencing where a study is conducted geographically to consider how Europe can compete with the USA or developing countries, such as China and India.


The European Conference will also feature an exhibition where a few select exhibitors will showcase their products and services to the conference delegates.


The 3rd ICR European Conference and Exhibition complements the 29th ICR Annual Spring Conference and Exhibition to be held at the ICC in Birmingham, UK on 8th and 9th April 2008 which regularly attracts more than 1,200 attendees.


ends


For further information, please contact:


Greg Simpson

BCS PR

Tel: 0115 9486901

Email: greg@bcspr.co.uk


Alan Needham

ICR

Tel: 01628 899 755

Email: aneedham@icr-global.org


 

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...